|
VCL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00750000001193E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32590000001542E-06 |
| Normal-vs-Stage2 |
1.92600000004095E-06 |
| Normal-vs-Stage3 |
3.598400E-03 |
| Normal-vs-Stage4 |
5.003500E-03 |
| Stage1-vs-Stage2 |
5.613000E-01 |
| Stage1-vs-Stage3 |
1.962990E-01 |
| Stage1-vs-Stage4 |
8.402400E-01 |
| Stage2-vs-Stage3 |
1.218800E-01 |
| Stage2-vs-Stage4 |
5.739600E-01 |
| Stage3-vs-Stage4 |
5.377800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.76330103033251E-11 |
| Normal-vs-AfricanAmerican |
1.5891699999937E-05 |
| Normal-vs-Asian |
3.326400E-02 |
| Caucasian-vs-AfricanAmerican |
5.362400E-01 |
| Caucasian-vs-Asian |
6.901800E-01 |
| AfricanAmerican-vs-Asian |
8.385000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64459999951738E-07 |
| Normal-vs-Female |
5.043800E-03 |
| Male-vs-Female |
1.13400000001374E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.41499999997785E-07 |
| Normal-vs-Extreme_Weight |
1.9035999998529E-07 |
| Normal-vs-Obese |
2.770600E-04 |
| Normal-vs-Extreme_Obese |
4.47000000014519E-07 |
| Normal_Weight-vs-Extreme_Weight |
5.554800E-01 |
| Normal_Weight-vs-Obese |
9.509500E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.033000E-01 |
| Extreme_Weight-vs-Obese |
1.414200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.259800E-01 |
| Obese-vs-Extreme_Obese |
1.185950E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.998000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.8346000002788E-07 |
| Normal-vs-Age(61-80Yrs) |
2.02349999978146E-07 |
| Normal-vs-Age(81-100Yrs) |
7.27590000471068E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.687400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.368200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.522300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.835600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.936500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.205800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.48530000041592E-07 |
| Normal-VS-Type2 PRCC |
9.38990000198814E-08 |
| Normal-VS-KIRP CIMP |
6.255000E-01 |
| Normal-VS-Unclassified PRCC |
4.764000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.116410E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.803500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.920200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.204600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.835730E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.743000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.04180000076926E-08 |
| Normal-vs-N1 |
1.030480E-02 |
| Normal-vs-N2 |
2.816200E-01 |
| N0-vs-N1 |
1.846400E-02 |
| N0-vs-N2 |
3.549800E-02 |
| N1-vs-N2 |
8.008800E-01 |
|
|
